Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

状細胞の危機に対するオピオイドは?

D H Bevan

    Lancet (London, England)
    |July 8, 1998
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Sickle cell 'girdle syndrome' progressing to ischaemic colitis and colonic perforation.

    Clinical and laboratory haematology·2006
    Same author

    A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK.

    British journal of haematology·2004
    Same author

    Platelet pheresis is not a useful adjunct to blood-sparing strategies in cardiac surgery.

    Journal of cardiothoracic and vascular anesthesia·2002
    Same author

    Thromboelastography: a reliable test?

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2001
    Same author

    The effect of treatment with Campath-1H in patients with autoimmune cytopenias.

    British journal of haematology·2001
    Same author

    Red cell exchange, erythrocytapheresis, in the treatment of malaria with high parasitaemia in returning travellers.

    Transactions of the Royal Society of Tropical Medicine and Hygiene·2000
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る